Thermo Fisher Scientific Inc. (LON:0R0H)
590.54
+0.09 (0.02%)
At close: Nov 28, 2025
Thermo Fisher Scientific Revenue
Thermo Fisher Scientific had revenue of $11.12B USD in the quarter ending September 27, 2025, with 4.94% growth. This brings the company's revenue in the last twelve months to $43.74B, up 3.22% year-over-year. In the year 2024, Thermo Fisher Scientific had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$43.74B
Revenue Growth
+3.22%
P/S Ratio
5.14
Revenue / Employee
$349.88K
Employees
125,000
Market Cap
167.69B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | 25.54B | 1.18B | 4.86% |
| Dec 31, 2018 | 24.36B | 3.44B | 16.45% |
| Dec 31, 2017 | 20.92B | 2.64B | 14.47% |
| Dec 31, 2016 | 18.27B | 1.31B | 7.72% |
| Dec 31, 2015 | 16.97B | 75.40M | 0.45% |
| Dec 31, 2014 | 16.89B | 3.80B | 29.02% |
| Dec 31, 2013 | 13.09B | 580.40M | 4.64% |
| Dec 31, 2012 | 12.51B | 951.10M | 8.23% |
| Dec 31, 2011 | 11.56B | 1.17B | 11.22% |
| Dec 31, 2010 | 10.39B | 481.50M | 4.86% |
| Dec 31, 2009 | 9.91B | -586.40M | -5.59% |
| Dec 31, 2008 | 10.50B | 751.60M | 7.71% |
| Dec 31, 2007 | 9.75B | 5.95B | 157.05% |
| Dec 31, 2006 | 3.79B | 1.16B | 44.00% |
| Dec 31, 2005 | 2.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Thermo Fisher Scientific News
- 4 days ago - Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - Business Wire
- 8 days ago - Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report? - Nasdaq
- 9 days ago - Thermo Fisher Scientific's Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer - Business Wire
- 9 days ago - TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner - Nasdaq
- 10 days ago - Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing* - Business Wire
- 11 days ago - Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development - Business Wire
- 11 days ago - Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga
- 12 days ago - Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH - CNBC